199 related articles for article (PubMed ID: 20505783)
1. Saracatinib Impairs Head and Neck Squamous Cell Carcinoma Invasion by Disrupting Invadopodia Function.
Ammer AG; Kelley LC; Hayes KE; Evans JV; Lopez-Skinner LA; Martin KH; Frederick B; Rothschild BL; Raben D; Elvin P; Green TP; Weed SA
J Cancer Sci Ther; 2009 Nov; 1(2):52-61. PubMed ID: 20505783
[TBL] [Abstract][Full Text] [Related]
2. Ableson kinases negatively regulate invadopodia function and invasion in head and neck squamous cell carcinoma by inhibiting an HB-EGF autocrine loop.
Hayes KE; Walk EL; Ammer AG; Kelley LC; Martin KH; Weed SA
Oncogene; 2013 Oct; 32(40):4766-77. PubMed ID: 23146907
[TBL] [Abstract][Full Text] [Related]
3. Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma.
Lang L; Shay C; Zhao X; Xiong Y; Wang X; Teng Y
J Hematol Oncol; 2019 Dec; 12(1):132. PubMed ID: 31805962
[TBL] [Abstract][Full Text] [Related]
4. Combating head and neck cancer metastases by targeting Src using multifunctional nanoparticle-based saracatinib.
Lang L; Shay C; Xiong Y; Thakkar P; Chemmalakuzhy R; Wang X; Teng Y
J Hematol Oncol; 2018 Jun; 11(1):85. PubMed ID: 29925404
[TBL] [Abstract][Full Text] [Related]
5. Cortactin Phosphorylation by Casein Kinase 2 Regulates Actin-Related Protein 2/3 Complex Activity, Invadopodia Function, and Tumor Cell Invasion.
Markwell SM; Ammer AG; Interval ET; Allen JL; Papenberg BW; Hames RA; Castaño JE; Schafer DA; Weed SA
Mol Cancer Res; 2019 Apr; 17(4):987-1001. PubMed ID: 30610108
[TBL] [Abstract][Full Text] [Related]
6. DCLK1-Mediated Regulation of Invadopodia Dynamics and Matrix Metalloproteinase Trafficking Drives Invasive Progression in Head and Neck Squamous Cell Carcinoma.
Arnold L; Yap M; Jackson L; Barry M; Ly T; Morrison A; Gomez JP; Washburn MP; Standing D; Yellapu NK; Li L; Umar S; Anant S; Thomas SM
bioRxiv; 2024 Apr; ():. PubMed ID: 38645056
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-375 Suppresses Extracellular Matrix Degradation and Invadopodial Activity in Head and Neck Squamous Cell Carcinoma.
Jimenez L; Sharma VP; Condeelis J; Harris T; Ow TJ; Prystowsky MB; Childs G; Segall JE
Arch Pathol Lab Med; 2015 Nov; 139(11):1349-61. PubMed ID: 26172508
[TBL] [Abstract][Full Text] [Related]
8. Effect of the specific Src family kinase inhibitor saracatinib on osteolytic lesions using the PC-3 bone model.
Yang JC; Bai L; Yap S; Gao AC; Kung HJ; Evans CP
Mol Cancer Ther; 2010 Jun; 9(6):1629-37. PubMed ID: 20484016
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of Src inhibitor saracatinib (AZD-0530) in preclinical models of biliary tract carcinomas.
Cavalloni G; Peraldo-Neia C; Sarotto I; Gammaitoni L; Migliardi G; Soster M; Marchiò S; Aglietta M; Leone F
Mol Cancer Ther; 2012 Jul; 11(7):1528-38. PubMed ID: 22452946
[TBL] [Abstract][Full Text] [Related]
10. Combined inhibition of c-Src and epidermal growth factor receptor abrogates growth and invasion of head and neck squamous cell carcinoma.
Koppikar P; Choi SH; Egloff AM; Cai Q; Suzuki S; Freilino M; Nozawa H; Thomas SM; Gooding WE; Siegfried JM; Grandis JR
Clin Cancer Res; 2008 Jul; 14(13):4284-91. PubMed ID: 18594011
[TBL] [Abstract][Full Text] [Related]
11. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
Johnson FM; Saigal B; Talpaz M; Donato NJ
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma.
Allen JL; Hames RA; Mastroianni NM; Greenstein AE; Weed SA
Oral Oncol; 2022 Sep; 132():106008. PubMed ID: 35803110
[TBL] [Abstract][Full Text] [Related]
13. Combined inhibition of PLC{gamma}-1 and c-Src abrogates epidermal growth factor receptor-mediated head and neck squamous cell carcinoma invasion.
Nozawa H; Howell G; Suzuki S; Zhang Q; Qi Y; Klein-Seetharaman J; Wells A; Grandis JR; Thomas SM
Clin Cancer Res; 2008 Jul; 14(13):4336-44. PubMed ID: 18594017
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3 gallate inhibits cancer invasion by repressing functional invadopodia formation in oral squamous cell carcinoma.
Hwang YS; Park KK; Chung WY
Eur J Pharmacol; 2013 Sep; 715(1-3):286-95. PubMed ID: 23707351
[TBL] [Abstract][Full Text] [Related]
15. Anti-invasive and Anti-tumor Effects of Dryopteris crassirhizoma Extract by Disturbing Actin Polymerization.
Lee J; Nho YH; Yun SK; Hwang YS
Integr Cancer Ther; 2019; 18():1534735419851197. PubMed ID: 31109222
[TBL] [Abstract][Full Text] [Related]
16. The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042.
Hermida-Prado F; Villaronga MÁ; Granda-Díaz R; Del-Río-Ibisate N; Santos L; Hermosilla MA; Oro P; Allonca E; Agorreta J; Garmendia I; Tornín J; Perez-Escuredo J; Fuente R; Montuenga LM; Morís F; Rodrigo JP; Rodríguez R; García-Pedrero JM
J Clin Med; 2019 Aug; 8(8):. PubMed ID: 31382448
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer.
Nam HJ; Im SA; Oh DY; Elvin P; Kim HP; Yoon YK; Min A; Song SH; Han SW; Kim TY; Bang YJ
Mol Cancer Ther; 2013 Jan; 12(1):16-26. PubMed ID: 23144237
[TBL] [Abstract][Full Text] [Related]
18. Impact of the Src inhibitor saracatinib on the metastatic phenotype of a fibrosarcoma (KHT) tumor model.
Dong M; Rice L; Lepler S; Pampo C; Siemann DW
Anticancer Res; 2010 Nov; 30(11):4405-13. PubMed ID: 21115886
[TBL] [Abstract][Full Text] [Related]
19. Expression of human papillomavirus oncoproteins E6 and E7 inhibits invadopodia activity but promotes cell migration in HPV-positive head and neck squamous cell carcinoma cells.
Kahue CN; Jerrell RJ; Parekh A
Cancer Rep (Hoboken); 2018 Oct; 1(3):e1125. PubMed ID: 32721084
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Efficacy of Saracatinib-Loaded Nanoparticles in Lymphatic Metastases of HNSCC with the Aid of Bioluminescence Imaging.
Lang L; Teng Y
Methods Mol Biol; 2022; 2525():15-19. PubMed ID: 35836057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
